The recent advancement in high intensity focused ultrasound (HIFU) have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well-defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft-tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the advantages of non-invasion, non-ionization, and fewer complications after treatment. Over 100,000 cases have been treated throughout the world with great success.
The global market for High intensity focused ultrasound (HIFU) is increasing rapidly primarily driven by the increase in cancer patient’s population, growing demand for minimally invasive treatment procedures, and increasing public-private investments. The factors that influence the growth of HIFU Therapy are the increasing development in medical technology and its wide range of application used in the treatment of Prostate cancer, Uterine fibroids, Neurological disorders, Cosmetic medicine and others. Furthermore, stringent regulatory guidelines for the approval of innovative HIFU technologies, rising price pressure and unfavorable reimbursement scenario are the key challenges faced by market players restraining the growth of this market.
This is the 3rd edition report on High Intensity Focused Ultrasound (HIFU) Industry by iGATE RESEARCH. The report titled “Global High Intensity Focused Ultrasound (HIFU) - Company Profile, 20 Manufacturers Product Analysis and Recent Development” is a 267 Page report with 8 Figures and 41 Tables. This report provides a comprehensive assessment of the HIFU manufacturers, research sites, pre-clinical research sites, clinical research sites, technical research sites and commercial treatment sites. Furthermore, the company analysis segment covers attributes such as company overview, HIFU products and revenue analysis, and recent developments.
HIFU Company Profile - HIFU Products Analysis & Recent Developments 1. EDAP TMS 2. Haifu Medical 3. SonaCare Medical 4. Mianyang Sonic Electronic Ltd. 5. Shanghai A&S Co., LTD 6. Insightec 7. Alpinion Medical Systems 8. FUS Instruments 9. Theraclion 10. Image Guided Therapy 11. Eye Tech Care 12. Philips Healthcare 13. Profound Medical Corp 14. Promedica Bioelectronics 15. Shenzhen Wikkon 16. Sonic Concepts 17. Shenzhen PRO-HIFU Medical Tech. Co., Ltd. 18. Verasonics 19. Changjiangyuan Technology Development Co., Ltd 20. EpiSonica
The Global - High Intensity Focus Ultrasound (HIFU) report also covers • List of HIFU Manufacturers (North America, Europe, Asia, Global) • List of HIFU Research Sites (North America, South America, Europe, Asia, Oceania, Middle East, Global) • List of HIFU Pre-Clinical Research Sites (North America, South America, Europe, Asia, Oceania, Middle East, Global) • List of HIFU Clinical Research Sites (North America, South America, Europe, Asia, Oceania) • List of HIFU Technical Research Sites (North America, Europe, Asia, Middle East, Global) • List of HIFU Commercial Treatment Sites (North America, South America, Europe, Asia, Oceania)
Companies Mentioned 1. EDAP TMS 2. Haifu Medical 3. SonaCare Medical 4. Mianyang Sonic Electronic Ltd. 5. Shanghai A&S Co., LTD 6. Insightec 7. Alpinion Medical Systems 8. FUS Instruments 9. Theraclion 10. Image Guided Therapy 11. Eye Tech Care 12. Philips Healthcare 13. Profound Medical Corp 14. Promedica Bioelectronics 15. Shenzhen Wikkon 16. Sonic Concepts 17. Shenzhen PRO-HIFU Medical Tech. Co., Ltd. 18. Verasonics 19. Changjiangyuan Technology Development Co., Ltd 20. EpiSonica
Our reports have been used by over 10K customers, including:
256 pages •
By Roots Analysis Private Ltd.
• Feb 2021
INTRODUCTION Over time, advances in molecular biology and pharmacological chemistry have enabled the identification of biological targets localized in the subcellular space, and development of therapeutic leads against them. In fact, there are several clinical conditions, which were previously considered undruggable since...
The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By End Use (Healthcare Providers, Homecare), By Technology (Bluetooth, NFC), By Region, And Segment Forecasts, 2020 - 2027
Connected Drug Delivery Devices Market Growth & Trends
The global connected drug...
Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields.The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, physical medicine and...
510 pages •
By Roots Analysis Private Ltd.
• May 2020
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
Increasing demand from drug delivery and catheters and cannulas to drive the overall growth of the medical tubing market The US medical tubing market size is expected to grow from USD 2.6 billion in 2020 to USD 2.9 billion by 2021, at a CAGR of 13.2% during the forecast period. The medical tubing industry is driven by various...
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
The bioresorbable medical material was valued at US$ 935.99 million in 2019 and is expected to grow at a CAGR of 9.7% from 2020 to 2027 to reach US$ 1,942.13 million by 2027. Driving factors of the bioresorbable medical material market are rising adoption of bioresorbable polymers for medical use and increasing number of orthopedic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.